TTK Healthcare Operational Benchmarking
₹1,009.30-3.56%close, 9 Oct 2026
- Market cap
- ₹1,426 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹726.70 – ₹1,362.56
TTK Healthcare compared with sector peers on revenue, market capitalization, valuation, and return metrics.
TTK Healthcare sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| TTK Healthcare Limited | ₹1,009.30 | 22.5 | 1,426 | 1.2% | 357 | 14.5% |
| Median (1 Cos) | ₹1,009.30 | 22.5 | 1,426 | 1.2% | 357 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Unichem Laboratories Limited operational benchmarking
- Torrent Pharmaceuticals Limited operational benchmarking
- Vaishali Pharma Limited operational benchmarking
- Thyrocare Technologies Limited operational benchmarking
- Valiant Laboratories Limited operational benchmarking
- Themis Medicare Limited operational benchmarking
Trade TTK Healthcare With ATS
Track TTKHLTCARE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.